Forecasting the development of antimicrobial resistance of S. aureus

Today, about 15.0% of odontogenic pathology is caused by Staphylococcus aureus (S. aureus). The aim of the study was to predict the development of antimicrobial resistance of S. aureus based on retrospective data.MethodsA total of 425 patients undergoing treatment for odontogenic infectious diseases...

Full description

Saved in:
Bibliographic Details
Main Authors: Oleh Shemetov, Mariia Faustova, Tetiana Perepelova, Hennadii Balia, Ihor Pavlish, Galina Loban'
Format: Article
Language:English
Published: Frontiers Media S.A. 2025-01-01
Series:Frontiers in Oral Health
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/froh.2024.1514070/full
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1841553863755169792
author Oleh Shemetov
Mariia Faustova
Tetiana Perepelova
Hennadii Balia
Ihor Pavlish
Galina Loban'
author_facet Oleh Shemetov
Mariia Faustova
Tetiana Perepelova
Hennadii Balia
Ihor Pavlish
Galina Loban'
author_sort Oleh Shemetov
collection DOAJ
description Today, about 15.0% of odontogenic pathology is caused by Staphylococcus aureus (S. aureus). The aim of the study was to predict the development of antimicrobial resistance of S. aureus based on retrospective data.MethodsA total of 425 patients undergoing treatment for odontogenic infectious diseases of the facial area during 2019–2023 were involved in the study. The object of the study was 106 clinical isolates of S. aureus that were isolated and identified from patients. Determining the sensitivity of the obtained isolates to antimicrobial drugs was carried out using Vitek antimicrobial susceptibility testing (Biomerioux, France) and analyzed according to the breackpoint tables of the EUCAST. Prediction of the development of antimicrobial resistance of S. aureus to various antibiotics was carried out on the basis of the received sensitivity data of the studied isolates in 2019–2023 using the exponential smoothing method.ResultsThe antimicrobial resistance of S. aureus isolates to various antibiotics changed annually during 2019–2023. The level of resistance of S. aureus isolates to benzylpenicillin wavered between 40%–50% from 2019 to 2023 with the trend of an 18.0% increase over the next five years. A uniform plateau of antimicrobial resistance of S. aureus to cefoxitin is predicted at the level of 32.0% during 2024–2028. We recorded the highest portions of S. aureus resistant to norfloxacin (33.3%) and ciprofloxacin (16.7%) in 2023 with prediction of its increasing in the next five years within the range of 20.0%. It was established that S. aureus may reach 100.0% resistance to gentamicin in 2027. According to exponential smoothing, the level of S. aureus resistance to amikacin will increase by 22.7% over the next five-year period. Moreover, representatives of this species of bacteria can develop complete (100.0%) resistance to tetracycline as early as 2027.ConclusionsMathematical prediction of the development of antimicrobial sensitivity of S. aureus isolates showed a high probability of its development to antibiotics of all groups in the next five years.
format Article
id doaj-art-0210a83461e6494d8ba998bfafc8af5a
institution Kabale University
issn 2673-4842
language English
publishDate 2025-01-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Oral Health
spelling doaj-art-0210a83461e6494d8ba998bfafc8af5a2025-01-09T06:10:38ZengFrontiers Media S.A.Frontiers in Oral Health2673-48422025-01-01510.3389/froh.2024.15140701514070Forecasting the development of antimicrobial resistance of S. aureusOleh Shemetov0Mariia Faustova1Tetiana Perepelova2Hennadii Balia3Ihor Pavlish4Galina Loban'5Department of Prosthetics Dentistry with Implantology, Poltava State Medical University, Poltava, UkraineDepartment of Microbiology, Virology and Immunology, Poltava State Medical University, Poltava, UkraineDepartment of Prosthetics Dentistry with Implantology, Poltava State Medical University, Poltava, UkraineDepartment of Prosthetics Dentistry with Implantology, Poltava State Medical University, Poltava, UkraineDepartment of Prosthetics Dentistry with Implantology, Poltava State Medical University, Poltava, UkraineDepartment of Microbiology, Virology and Immunology, Poltava State Medical University, Poltava, UkraineToday, about 15.0% of odontogenic pathology is caused by Staphylococcus aureus (S. aureus). The aim of the study was to predict the development of antimicrobial resistance of S. aureus based on retrospective data.MethodsA total of 425 patients undergoing treatment for odontogenic infectious diseases of the facial area during 2019–2023 were involved in the study. The object of the study was 106 clinical isolates of S. aureus that were isolated and identified from patients. Determining the sensitivity of the obtained isolates to antimicrobial drugs was carried out using Vitek antimicrobial susceptibility testing (Biomerioux, France) and analyzed according to the breackpoint tables of the EUCAST. Prediction of the development of antimicrobial resistance of S. aureus to various antibiotics was carried out on the basis of the received sensitivity data of the studied isolates in 2019–2023 using the exponential smoothing method.ResultsThe antimicrobial resistance of S. aureus isolates to various antibiotics changed annually during 2019–2023. The level of resistance of S. aureus isolates to benzylpenicillin wavered between 40%–50% from 2019 to 2023 with the trend of an 18.0% increase over the next five years. A uniform plateau of antimicrobial resistance of S. aureus to cefoxitin is predicted at the level of 32.0% during 2024–2028. We recorded the highest portions of S. aureus resistant to norfloxacin (33.3%) and ciprofloxacin (16.7%) in 2023 with prediction of its increasing in the next five years within the range of 20.0%. It was established that S. aureus may reach 100.0% resistance to gentamicin in 2027. According to exponential smoothing, the level of S. aureus resistance to amikacin will increase by 22.7% over the next five-year period. Moreover, representatives of this species of bacteria can develop complete (100.0%) resistance to tetracycline as early as 2027.ConclusionsMathematical prediction of the development of antimicrobial sensitivity of S. aureus isolates showed a high probability of its development to antibiotics of all groups in the next five years.https://www.frontiersin.org/articles/10.3389/froh.2024.1514070/fullantimicrobial resistanceS. aureusantibioticsodontogenic infectionsphlegmonsforecasting
spellingShingle Oleh Shemetov
Mariia Faustova
Tetiana Perepelova
Hennadii Balia
Ihor Pavlish
Galina Loban'
Forecasting the development of antimicrobial resistance of S. aureus
Frontiers in Oral Health
antimicrobial resistance
S. aureus
antibiotics
odontogenic infections
phlegmons
forecasting
title Forecasting the development of antimicrobial resistance of S. aureus
title_full Forecasting the development of antimicrobial resistance of S. aureus
title_fullStr Forecasting the development of antimicrobial resistance of S. aureus
title_full_unstemmed Forecasting the development of antimicrobial resistance of S. aureus
title_short Forecasting the development of antimicrobial resistance of S. aureus
title_sort forecasting the development of antimicrobial resistance of s aureus
topic antimicrobial resistance
S. aureus
antibiotics
odontogenic infections
phlegmons
forecasting
url https://www.frontiersin.org/articles/10.3389/froh.2024.1514070/full
work_keys_str_mv AT olehshemetov forecastingthedevelopmentofantimicrobialresistanceofsaureus
AT mariiafaustova forecastingthedevelopmentofantimicrobialresistanceofsaureus
AT tetianaperepelova forecastingthedevelopmentofantimicrobialresistanceofsaureus
AT hennadiibalia forecastingthedevelopmentofantimicrobialresistanceofsaureus
AT ihorpavlish forecastingthedevelopmentofantimicrobialresistanceofsaureus
AT galinaloban forecastingthedevelopmentofantimicrobialresistanceofsaureus